Company Quick10K Filing
Vitamin Shoppe
10-Q 2019-09-28 Filed 2019-11-06
10-Q 2019-06-29 Filed 2019-08-08
10-Q 2019-03-30 Filed 2019-05-08
10-K 2018-12-29 Filed 2019-02-26
10-Q 2018-09-29 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-30 Filed 2018-02-27
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-07-01 Filed 2017-08-09
10-Q 2017-04-01 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-24 Filed 2016-11-02
10-Q 2016-06-25 Filed 2016-08-03
10-Q 2016-03-26 Filed 2016-05-04
10-K 2015-12-26 Filed 2016-02-23
10-Q 2015-09-26 Filed 2015-11-04
10-Q 2015-06-27 Filed 2015-08-05
10-Q 2015-03-28 Filed 2015-05-06
10-K 2014-12-27 Filed 2015-02-24
10-Q 2014-09-27 Filed 2014-11-04
10-Q 2014-06-28 Filed 2014-08-05
10-Q 2014-03-29 Filed 2014-05-07
10-K 2013-12-28 Filed 2014-02-25
10-Q 2013-09-28 Filed 2013-11-05
10-Q 2013-06-29 Filed 2013-08-06
10-Q 2013-03-30 Filed 2013-05-07
10-K 2012-12-29 Filed 2013-02-26
10-Q 2012-09-29 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-24 Filed 2011-10-28
10-Q 2011-06-25 Filed 2011-08-01
10-Q 2011-03-26 Filed 2011-05-04
10-K 2010-12-25 Filed 2011-03-09
10-Q 2010-09-25 Filed 2010-11-02
10-Q 2010-06-26 Filed 2010-08-05
10-Q 2010-03-27 Filed 2010-04-30
10-K 2009-12-26 Filed 2010-03-17
8-K 2019-12-16
8-K 2019-12-11
8-K 2019-11-11
8-K 2019-11-06
8-K 2019-09-23
8-K 2019-09-09
8-K 2019-08-08
8-K 2019-08-07
8-K 2019-06-06
8-K 2019-05-22
8-K 2019-05-08
8-K 2019-05-02
8-K 2019-03-25
8-K 2019-02-26
8-K 2018-11-07
8-K 2018-10-18
8-K 2018-08-24
8-K 2018-08-08
8-K 2018-07-30
8-K 2018-07-23
8-K 2018-06-28
8-K 2018-06-25
8-K 2018-06-07
8-K 2018-06-04
8-K 2018-05-18
8-K 2018-05-15
8-K 2018-05-09
8-K 2018-04-24
8-K 2018-04-20
8-K 2018-03-29
8-K 2018-02-27
8-K 2018-02-27

Vitamin Shoppe Financials

VSI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Cash725111450768131555474881532122321522232222222321516
Accounts Receivable7811101076576577633312111189109
Inventory112110121130120131138152153169164169189192187214211218227228230224242238233247234211202188189191181182
PP&E8080247858789268109114116321120131138368139139140398139140140436150152154488137137131430116115113
Assets466485491500528570586603635661682694722754722734730736749737741737734732582519489463420398388830816800
Accounts Payable17212219212422313632393530363751394441545651665654644748524440373738
Long-Term Debt22190000
Liabilities135140135122123135139132141148154139146169170176168171273287288277294281287308293277226205200641630618
Stockholders' Equity332345356378405436447471494512528554576586552557562565475449452460440451296211195186194193188189186182
Income Statement ($MM)2011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Revenue216209215248284239219279320272256308342309290337322314293337333315305317305288269296293277248283271253
Cost of Revenue142139140160179156142177203179171198222212195222214209202221225213205218218202183203199190168189181173
Gross Profit74697588105827610211693861091199795115108105911161081021009987868693948781959081
R&D
SG&A5352575864586067766767758377758485818089878212383878887898983898382
Tax810101217881518108141188129941087-1456-004202-1-0
Net Income121291823161021231611211712121914146151011-128-156-86-18-47-2-33-4-3
Cash Flow ($MM)2011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Cash Operating27157332217113482819173331626254431223152018513184802410
Cash Investing-5-10-6-5-8-13-62-12-9-11-9-92-12-12-11-9-10-9-12-9-10-9-10-18-15-12-77-5-8-7
Cash Financing-4-192912012-0333-4-39-5-15-1618-44-3-13-6-10010-1-12-553-2-2